Clinical trial

Pain Management of Anterior Cruciate Ligament Reconstruction: Evaluation of Adductor Canal Block Versus Oral Pain Regimen

Name

1115203

Description

This study will compare the outcome of pain interventions that are considered standard of care during the surgical treatment of ACL injuries. The comparison will be looking at pain control during and after ACL surgery as well as functional outcomes in patients that had a nerve block versus those who did not. The investigators hypothesize that pain control will be equal between both groups.

Trial arms

Trial start

2017-10-09

Estimated PCD

2024-07-01

Trial end

2024-07-01

Treatment

Adductor Canal Nerve Block

An adductor canal nerve block with 15 mL of 0.5% ropivacaine will be performed pre-operatively by Anesthesiology.

Arms:

Adductor Canal Nerve Block

Ropivacaine injection

15 mL of 0.5% ropivacaine will be administered for the adductor canal block

Arms:

Adductor Canal Nerve Block

Size

Primary endpoint

Immediate Post-op Pain Score

15 min post-op

Opioid Use

6 weeks post-op

Eligibility criteria

Inclusion Criteria: * Between the ages of 18 and 45 years old. * Clinical and/or advanced imaging confirmation of ACL tear of which reconstructive surgery is recommended and accepted. Exclusion Criteria: * No prior surgery of the affected and contralateral knee * Adults unable to consent * Children (age \< 18 years old) * Prisoners * Pregnant women * Inflammatory arthritis * Non-English-speaking patients

Protocol

{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'maskingDescription': 'Operating surgeon and outcome assessor will be blind to whether patient had nerve block prior to OR.', 'whoMasked': ['INVESTIGATOR', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 60, 'type': 'ESTIMATED'}}

Updated at

2024-05-17

1 organization

1 product

1 indication

Organization

University of California, Davis

Product

Ropivacaine

Indication

Anterior Cruciate Ligament Rupture